Saw palmetto

DB14360Approved

Saw palmetto is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Mechanism: Pharmacologically active on Androgen receptor, 3-oxo-5-alpha-steroid 4-dehydrogenase 1, and 3-oxo-5-alpha-steroid 4-dehydrogenase 2
Curator reviewed
First approval: Canada, 1998
Also known as: Abal Fructus · Brahea Serrulata Fruit · Chamaerops Serrulata Fruit · Corypha Obliqua Fruit · Corypha Repens Fruit

Resolves to

Compound

Clinical / RWD

Targets

What you can answer from here — as of September 17, 2026

4Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

3Structured indicationsCondition, population, route and combination as fields, not prose

56Marketed productsAcross 6 countries and 15 labellers

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Saw palmetto, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.